184 related articles for article (PubMed ID: 23030601)
1. Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.
Olsson SK; Sellgren C; Engberg G; Landén M; Erhardt S
Bipolar Disord; 2012 Nov; 14(7):719-26. PubMed ID: 23030601
[TBL] [Abstract][Full Text] [Related]
2. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
[TBL] [Abstract][Full Text] [Related]
3. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
[TBL] [Abstract][Full Text] [Related]
4. Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.
Atlas A; Gisslén M; Nordin C; Lindström L; Schwieler L
Brain Behav Immun; 2007 Jan; 21(1):86-91. PubMed ID: 16603336
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.
Olsson SK; Samuelsson M; Saetre P; Lindström L; Jönsson EG; Nordin C; Engberg G; Erhardt S; Landén M
J Psychiatry Neurosci; 2010 May; 35(3):195-9. PubMed ID: 20420770
[TBL] [Abstract][Full Text] [Related]
6. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls.
Sellgren CM; Gracias J; Jungholm O; Perlis RH; Engberg G; Schwieler L; Landen M; Erhardt S
Transl Psychiatry; 2019 Jan; 9(1):37. PubMed ID: 30696814
[TBL] [Abstract][Full Text] [Related]
8. Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis.
Holtze M; Mickiené A; Atlas A; Lindquist L; Schwieler L
J Intern Med; 2012 Oct; 272(4):394-401. PubMed ID: 22443218
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
Sellgren CM; Kegel ME; Bergen SE; Ekman CJ; Olsson S; Larsson M; Vawter MP; Backlund L; Sullivan PF; Sklar P; Smoller JW; Magnusson PK; Hultman CM; Walther-Jallow L; Svensson CI; Lichtenstein P; Schalling M; Engberg G; Erhardt S; Landén M
Mol Psychiatry; 2016 Oct; 21(10):1342-50. PubMed ID: 26666201
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
Nilsson LK; Linderholm KR; Engberg G; Paulson L; Blennow K; Lindström LH; Nordin C; Karanti A; Persson P; Erhardt S
Schizophr Res; 2005 Dec; 80(2-3):315-22. PubMed ID: 16125901
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
12. CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis.
Carlborg A; Jokinen J; Jönsson EG; Erhardt S; Nordström P
Psychiatry Res; 2013 Jan; 205(1-2):165-7. PubMed ID: 22980480
[TBL] [Abstract][Full Text] [Related]
13. Polarity at illness onset in bipolar I disorder and clinical course of illness.
Forty L; Jones L; Jones I; Smith DJ; Caesar S; Fraser C; Gordon-Smith K; Hyde S; Craddock N
Bipolar Disord; 2009 Feb; 11(1):82-8. PubMed ID: 19133970
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
16. Psychotic features in bipolar and unipolar depression.
Goes FS; Sadler B; Toolan J; Zamoiski RD; Mondimore FM; Mackinnon DF; Schweizer B; ; Raymond Depaulo J; Potash JB
Bipolar Disord; 2007 Dec; 9(8):901-6. PubMed ID: 18076541
[TBL] [Abstract][Full Text] [Related]
17. Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics.
van der Werf-Eldering MJ; van der Meer L; Burger H; Holthausen EA; Nolen WA; Aleman A
Bipolar Disord; 2011 Jun; 13(4):343-54. PubMed ID: 21843274
[TBL] [Abstract][Full Text] [Related]
18. Sustained attention deficits in manic and euthymic patients with bipolar disorder.
Bora E; Vahip S; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1097-102. PubMed ID: 16740350
[TBL] [Abstract][Full Text] [Related]
19. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
